Philippe Beutels
#155,695
Most Influential Person Now
Researcher
Philippe Beutels's AcademicInfluence.com Rankings
Philippe Beutelsphilosophy Degrees
Philosophy
#8802
World Rank
#12254
Historical Rank
Logic
#5820
World Rank
#7260
Historical Rank

Download Badge
Philosophy
Philippe Beutels's Degrees
- Masters Public Health University of Antwerp
Why Is Philippe Beutels Influential?
(Suggest an Edit or Addition)Philippe Beutels's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Social Contacts and Mixing Patterns Relevant to the Spread of Infectious Diseases (2008) (2491)
- Rotavirus disease and vaccination: impact on genotype diversity. (2009) (296)
- Global burden of disease (GBD) for hepatitis C (2004) (291)
- Dynamic Epidemiological Models for Dengue Transmission: A Systematic Review of Structural Approaches (2012) (272)
- Precautionary Behavior in Response to Perceived Threat of Pandemic Influenza (2007) (243)
- Behavioural change models for infectious disease transmission: a systematic review (2010–2015) (2016) (235)
- WHO Guide for standardisation of economic evaluations of immunization programmes. (2010) (207)
- Estimating the impact of school closure on social mixing behaviour and the transmission of close contact infections in eight European countries (2009) (200)
- Global Disease Burden Estimates of Respiratory Syncytial Virus-Associated Acute Respiratory Infection in Older Adults in 2015: A Systematic Review and Meta-Analysis. (2019) (164)
- The possible macroeconomic impact on the UK of an influenza pandemic. (2010) (163)
- The French Connection: The First Large Population-Based Contact Survey in France Relevant for the Spread of Infectious Diseases (2015) (162)
- Health Economics of Dengue: A Systematic Literature Review and Expert Panel's Assessment (2011) (161)
- Indications for healthcare surge capacity in European countries facing an exponential increase in coronavirus disease (COVID-19) cases, March 2020 (2020) (150)
- The macroeconomic impact of pandemic influenza: estimates from models of the United Kingdom, France, Belgium and The Netherlands (2010) (150)
- Accounting for Methodological, Structural, and Parameter Uncertainty in Decision-Analytic Models (2011) (144)
- Cost-effectiveness analyses of human papillomavirus vaccination. (2007) (142)
- Economic evaluations of hepatitis B immunization: a global review of recent studies (1994-2000). (2001) (133)
- Additional hospital stay and charges due to hospital-acquired infections in a neonatal intensive care unit. (2001) (127)
- Social mixing patterns for transmission models of close contact infections: exploring self-evaluation and diary-based data collection through a web-based interface (2006) (126)
- Modeling Infectious Disease Parameters Based on Serological and Social Contact Data (2012) (123)
- The cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe. (2009) (122)
- Parvovirus B19 infection in five European countries: seroepidemiology, force of infection and maternal risk of infection (2007) (118)
- Mining social mixing patterns for infectious disease models based on a two-day population survey in Belgium (2009) (116)
- Lessons from a decade of individual-based models for infectious disease transmission: a systematic review (2006-2015) (2017) (112)
- Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis (2022) (110)
- Immunogenicity, efficacy, safety and effectiveness of pneumococcal conjugate vaccines (1998-2006). (2007) (110)
- Estimating infectious disease parameters from data on social contacts and serological status (2009) (108)
- Herpes Zoster Risk Reduction through Exposure to Chickenpox Patients: A Systematic Multidisciplinary Review (2013) (108)
- Costs and benefits of routine varicella vaccination in German children. (1996) (106)
- The economic impact of SARS in Beijing, China (2009) (97)
- Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community (2015) (95)
- The Burden of Rotavirus Acute Gastroenteritis in Europe (2010) (95)
- Seventy-five years of estimating the force of infection from current status data (2009) (92)
- Global Burden of Disease (GBD) for Hepatitis C The Global Burden of Hepatitis C Working Group (2004) (88)
- Convincing or confusing? Economic evaluations of childhood pneumococcal conjugate vaccination--a review (2002-2006). (2007) (83)
- Economic Evaluations of Varicella Vaccination Programmes (2003) (81)
- Influenza epidemiology and immunization during pregnancy: Final report of a World Health Organization working group (2017) (79)
- Using empirical social contact data to model person to person infectious disease transmission: an illustration for varicella. (2009) (76)
- A Nice Day for an Infection? Weather Conditions and Social Contact Patterns Relevant to Influenza Transmission (2012) (74)
- A Systematic Review of Social Contact Surveys to Inform Transmission Models of Close-contact Infections (2019) (70)
- Economic evaluation of vaccination programmes: a consensus statement focusing on viral hepatitis. (2002) (69)
- Living on Three Time Scales: The Dynamics of Plasma Cell and Antibody Populations Illustrated for Hepatitis A Virus (2012) (68)
- A systematic review of social contact surveys to inform transmission models of close contact infections (2018) (68)
- Partially wrong? Partial equilibrium and the economic analysis of public health emergencies of international concern. (2008) (65)
- The Etiological Role of Common Respiratory Viruses in Acute Respiratory Infections in Older Adults: A Systematic Review and Meta-analysis (2018) (65)
- CoMix: comparing mixing patterns in the Belgian population during and after lockdown (2020) (64)
- Mathematical models for assessment of long‐term persistence of antibodies after vaccination with two inactivated hepatitis A vaccines (2000) (64)
- Seroprevalence of IgG antibodies against SARS coronavirus 2 in Belgium: a prospective cross-sectional study of residual samples (2020) (63)
- The Social Value Of Vaccination Programs: Beyond Cost-Effectiveness. (2016) (63)
- Funding of drugs: do vaccines warrant a different approach? (2008) (62)
- Cost-Effectiveness of Rotavirus Vaccination: Exploring Caregiver(s) and ``No Medical Care'' Disease Impact in Belgium (2009) (62)
- The health and economic burden of chickenpox and herpes zoster in Belgium (2012) (62)
- Modelling age‐dependent force of infection from prevalence data using fractional polynomials (2006) (61)
- A look into the future of the COVID-19 pandemic in Europe: an expert consultation (2021) (61)
- COVID-19 and retail: The catalyst for e-commerce in Belgium? (2021) (60)
- Prevaccination Distribution of Human Papillomavirus Types in Women Attending at Cervical Cancer Screening in Belgium (2009) (60)
- Methodological issues and new developments in the economic evaluation of vaccines (2003) (60)
- Hepatitis B prevention in Europe: a preliminary economic evaluation. (1995) (60)
- Economic Evaluation of Vaccination Programmes (2002) (58)
- Reviewing the Cost Effectiveness of Rotavirus Vaccination (2012) (57)
- SOCRATES: an online tool leveraging a social contact data sharing initiative to assess mitigation strategies for COVID-19 (2020) (57)
- The seroepidemiology of primary varicella-zoster virus infection in Flanders (Belgium) (2002) (57)
- Public preferences for prioritizing preventive and curative health care interventions: a discrete choice experiment. (2015) (56)
- The impact of contact tracing and household bubbles on deconfinement strategies for COVID-19 (2020) (54)
- Estimating the Incidence of Symptomatic Rotavirus Infections: A Systematic Review and Meta-Analysis (2009) (53)
- Modelling the early phase of the Belgian COVID-19 epidemic using a stochastic compartmental model and studying its implied future trajectories (2020) (53)
- Costing Infectious Disease Outbreaks for Economic Evaluation (2012) (53)
- Are we hitting immunity targets? The 2006 age-specific seroprevalence of measles, mumps, rubella, diphtheria and tetanus in Belgium (2010) (52)
- The cost-effectiveness of rotavirus vaccination in Australia. (2007) (51)
- Individual decisions to vaccinate one's child or oneself: A discrete choice experiment rejecting free-riding motives. (2018) (49)
- Determinants of between-country differences in ambulatory antibiotic use and antibiotic resistance in Europe: a longitudinal observational study. (2014) (48)
- Appropriate international measures for outpatient antibiotic prescribing and consumption: recommendations from a national data comparison of different measures. (2014) (47)
- Estimating dynamic transmission model parameters for seasonal influenza by fitting to age and season-specific influenza-like illness incidence. (2015) (47)
- Choosing between 7-, 10- and 13-valent pneumococcal conjugate vaccines in childhood: a review of economic evaluations (2006-2014). (2015) (46)
- An update to "The cost-effectiveness of rotavirus vaccination: comparative analyses for five European countries and transferability in Europe". (2010) (46)
- An economic evaluation of varicella vaccination in Italian adolescents. (2004) (45)
- Global and Regional Burden of Hospital Admissions for Pneumonia in Older Adults: A Systematic Review and Meta-Analysis. (2019) (45)
- Childhood varicella-zoster virus vaccination in Belgium: Cost-effective only in the long run or without exogenous boosting? (2013) (44)
- Influenza-Like-Illness and Clinically Diagnosed Flu: Disease Burden, Costs and Quality of Life for Patients Seeking Ambulatory Care or No Professional Care at All (2014) (42)
- A simple periodic-forced model for dengue fitted to incidence data in Singapore. (2013) (42)
- Sustained low rotavirus activity and hospitalisation rates in the post-vaccination era in Belgium, 2007 to 2014. (2016) (42)
- Key issues for estimating the impact and cost-effectiveness of seasonal influenza vaccination strategies (2013) (41)
- Association Between Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infection in Early Life and Recurrent Wheeze and Asthma in Later Childhood. (2019) (39)
- Estimating the effective reproduction number for pandemic influenza from notification data made publicly available in real time: a multi-country analysis for influenza A/H1N1v 2009. (2011) (38)
- Cost of Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infection Management in Young Children at the Regional and Global Level: A Systematic Review and Meta-Analysis. (2020) (37)
- Cost of Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infection Management in Young Children at the Regional and Global Level: A Systematic Review and Meta-Analysis. (2020) (37)
- A Systematic Review of Clinical Practice Guidelines for the Diagnosis and Management of Bronchiolitis. (2020) (36)
- An economic evaluation of universal pertussis vaccination in Italy. (1999) (36)
- Economic evaluations of varicella vaccination programmes: a review of the literature. (2003) (36)
- Like mother, like daughter? Mother's history of cervical cancer screening and daughter's Human Papillomavirus vaccine uptake in Flanders (Belgium). (2011) (36)
- Health and economic burden of respiratory syncytial virus (RSV) disease and the cost-effectiveness of potential interventions against RSV among children under 5 years in 72 Gavi-eligible countries (2020) (36)
- Integrating between-host transmission and within-host immunity to analyze the impact of varicella vaccination on zoster (2015) (35)
- Estimating Time of Infection Using Prior Serological and Individual Information Can Greatly Improve Incidence Estimation of Human and Wildlife Infections (2016) (35)
- Varicella vaccination in Australia (2005) (35)
- Guidelines for multi-model comparisons of the impact of infectious disease interventions (2019) (34)
- Exploring the impact of exposure to primary varicella in children on varicella-zoster virus immunity of parents. (2011) (33)
- The health and economic burden of haemophilia in Belgium: a rare, expensive and challenging disease (2014) (33)
- The health and economic burden of rotavirus disease in Belgium (2008) (32)
- Modelling forces of infection by using monotone local polynomials (2003) (32)
- Health‐related quality of life in patients with melanoma expressed as utilities and disability weights (2014) (31)
- Economic evaluation of options for measles vaccination strategy in a hypothetical Western European country (2003) (31)
- Transcriptome profiling in blood before and after hepatitis B vaccination shows significant differences in gene expression between responders and non-responders. (2018) (30)
- Resurgence risk for measles, mumps and rubella in France in 2018 and 2020 (2018) (30)
- Potential conflicts of interest in vaccine economics research: a commentary with a case study of pneumococcal conjugate vaccination. (2004) (30)
- A data-driven metapopulation model for the Belgian COVID-19 epidemic: assessing the impact of lockdown and exit strategies (2020) (29)
- On discounting of health gains from human papillomavirus vaccination: effects of different approaches. (2012) (29)
- Pharmaco-economic evaluation of targeted hepatitis A vaccination for children of ethnic minorities in Amsterdam (The Netherlands). (2004) (29)
- Cost-effectiveness of vaccination against herpes zoster in adults aged over 60 years in Belgium. (2012) (29)
- Multidisciplinary study of the secondary immune response in grandparents re-exposed to chickenpox (2017) (29)
- Universal hepatitis B vaccination in Belgium (2013) (28)
- Economic evaluations applied to HB vaccination: general observations. (1998) (28)
- Cost-effectiveness of contemporary vascular closure devices for the prevention of vascular complications after percutaneous coronary interventions in an all-comers PCI population. (2014) (28)
- The social contact hypothesis under the assumption of endemic equilibrium: Elucidating the transmission potential of VZV in Europe. (2015) (28)
- The potential influence of various initiatives to improve rational prescribing for proton pump inhibitors and statins in Belgium (2013) (28)
- Serology indicates cytomegalovirus infection is associated with varicella‐zoster virus reactivation (2014) (28)
- Estimating the age-specific duration of herpes zoster vaccine protection: a matter of model choice? (2012) (27)
- Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape. (2022) (27)
- Influence of Frequent Infectious Exposures on General and Varicella-Zoster Virus-Specific Immune Responses in Pediatricians (2014) (27)
- Model structure analysis to estimate basic immunological processes and maternal risk for parvovirus B19 (2010) (27)
- The cost-effectiveness of pneumococcal vaccination in healthy adults over 50: An exploration of influential factors for Belgium. (2016) (27)
- SOCRATES-CoMix: a platform for timely and open-source contact mixing data during and in between COVID-19 surges and interventions in over 20 European countries (2021) (27)
- Household members do not contact each other at random: implications for infectious disease modelling (2017) (27)
- Active Learning to Understand Infectious Disease Models and Improve Policy Making (2014) (27)
- Consumer choice between common generic and brand medicines in a country with a small generic market. (2015) (26)
- Assessing the risk of measles resurgence in a highly vaccinated population: Belgium anno 2013. (2015) (26)
- The role of economic evaluation in vaccine decision making (2012) (26)
- Drivers of vaccine decision-making in South Africa: A discrete choice experiment. (2019) (25)
- Preferential differences in vaccination decision-making for oneself or one’s child in The Netherlands: a discrete choice experiment (2020) (25)
- Estimating the population prevalence and force of infection directly from antibody titres (2012) (25)
- An economic evaluation of hepatitis A vaccination in Dutch military personnel. (1998) (25)
- Selective Use of Sequential Digital Dermoscopy Imaging Allows a Cost Reduction in the Melanoma Detection Process: A Belgian Study of Patients with a Single or a Small Number of Atypical Nevi (2014) (25)
- Introduction of human papillomavirus (HPV) vaccination in Belgium, 2007-2008. (2009) (25)
- Economic evaluations of implemented vaccination programmes: key methodological challenges in retrospective analyses. (2014) (25)
- Patient and prescriber determinants for the choice between amoxicillin and broader-spectrum antibiotics: a nationwide prescription-level analysis. (2013) (25)
- A brief history of economic evaluation for human papillomavirus vaccination policy. (2010) (24)
- Application of mixed-effects models to study the country-specific outpatient antibiotic use in Europe: a tutorial on longitudinal data analysis. (2011) (24)
- Immunogenicity and persistence of trivalent measles, mumps, and rubella vaccines: a systematic review and meta-analysis (2020) (24)
- Economic Evaluations of Childhood Influenza Vaccination (2012) (24)
- Valuing prevention through economic evaluation: some considerations regarding the choice of discount model for health effects with focus on infectious diseases. (2004) (24)
- Towards a European strategy to address the COVID-19 pandemic (2021) (24)
- Vaccination Policy and Ethical Challenges Posed by Herd Immunity, Suboptimal Uptake and Subgroup Targeting (2011) (24)
- Kicking against the pricks: vaccine sceptics have a different social orientation. (2014) (23)
- Assessing mumps outbreak risk in highly vaccinated populations using spatial seroprevalence data. (2014) (23)
- Beyond expectations: Post-implementation data shows rotavirus vaccination is likely cost-saving in Australia. (2017) (22)
- Modelling multisera data: The estimation of new joint and conditional epidemiological parameters (2008) (22)
- The difficult quest for data on "vanishing" vaccine-preventable infections in Europe: the case of measles in Flanders (Belgium). (2002) (22)
- POTENTIAL IMPACT OF POLICY REGULATION AND GENERIC COMPETITION ON SALES OF CHOLESTEROL LOWERING MEDICATION, ANTIDEPRESSANTS AND ACID BLOCKING AGENTS IN BELGIUM (2012) (21)
- Respiratory Syncytial Virus-Associated Hospital Admissions in Children Younger Than 5 Years in 7 European Countries Using Routinely Collected Datasets. (2020) (21)
- Individual factors influencing COVID-19 vaccine acceptance in between and during pandemic waves (July–December 2020) (2021) (21)
- The cost of measles in industrialised countries. (2003) (20)
- Memory CD4+ T cell receptor repertoire data mining as a tool for identifying cytomegalovirus serostatus (2018) (20)
- Varicella-Zoster Virus-Derived Major Histocompatibility Complex Class I-Restricted Peptide Affinity Is a Determining Factor in the HLA Risk Profile for the Development of Postherpetic Neuralgia (2014) (20)
- Cost effectiveness of pediatric pneumococcal conjugate vaccines: a comparative assessment of decision-making tools (2011) (19)
- Economic evaluation of pneumococcal vaccines for adults aged over 50 years in Belgium (2018) (19)
- Antivirals for influenza-Like Illness? A randomised Controlled trial of Clinical and Cost effectiveness in primary CarE (ALIC4 E): the ALIC4 E protocol (2018) (19)
- The macroeconomic costs of a global influenza pandemic (2008) (19)
- Contact patterns and their implied basic reproductive numbers: an illustration for varicella-zoster virus (2008) (19)
- Understanding the Cost-Effectiveness of Influenza Vaccination in Children: Methodological Choices and Seasonal Variability (2013) (19)
- Imputing QALYs from single time point health state descriptions on the EQ-5D and the SF-6D: a comparison of methods for hepatitis a patients. (2011) (19)
- POLYMOD social contact data (2017) (19)
- How nasopharyngeal pneumococcal carriage evolved during and after a PCV13-to-PCV10 vaccination programme switch in Belgium, 2016 to 2018 (2020) (18)
- Cost-effectiveness of seasonal influenza vaccination in pregnant women, health care workers and persons with underlying illnesses in Belgium. (2014) (18)
- Cost-effectiveness of hepatitis A vaccination in Indonesia (2014) (18)
- The Sexual Ethics of HPV Vaccination for Boys (2014) (18)
- Multi-country collaboration in responding to global infectious disease threats: lessons for Europe from the COVID-19 pandemic (2021) (18)
- Melanoma burden by melanoma stage: Assessment through a disease transition model. (2016) (17)
- Retrospective economic evaluation of childhood 7-valent pneumococcal conjugate vaccination in Australia: Uncertain herd impact on pneumonia critical. (2016) (17)
- Public preferences over efficiency, equity and autonomy in vaccination policy: an empirical study. (2013) (17)
- Economic evaluations of adult pneumococcal vaccination strategies (2001) (17)
- Evaluatie van universele en doelgroep hepatitis A vaccinatie opties in België = Evaluation of universal and targeted hepatitis A vaccination programs in Belgium (2008) (17)
- Close contact infection dynamics over time: insights from a second large-scale social contact survey in Flanders, Belgium, in 2010-2011 (2020) (17)
- The Cost of Arbovirus Disease Prevention in Europe: Area-Wide Integrated Control of Tiger Mosquito, Aedes albopictus, in Emilia-Romagna, Northern Italy (2017) (17)
- Economic aspects of pneumococcal pneumonia: a review of the literature. (2004) (16)
- Economic evaluation of vaccination programmes in humans: a methodological exploration with applications to hepatitis B, varicella-zoster, measles, pertussis, hepatitis A and pneumococcal vaccination (2002) (16)
- Community-acquired pneumonia (CAP) hospitalizations and deaths: is there a role for quality improvement through inter-hospital comparisons? (2016) (15)
- Hepatitis A infection in aircrews: risk of infection and cost-benefit analysis of hepatitis A vaccination. (1996) (15)
- Estimating the impact of vaccination using age–time-dependent incidence rates of hepatitis B (2007) (15)
- Acute Lower Respiratory Infections Associated With Respiratory Syncytial Virus in Children With Underlying Congenital Heart Disease: Systematic Review and Meta-analysis. (2019) (15)
- Cost-effectiveness of 13-valent pneumococcal conjugate vaccine (PCV13) in older Australians. (2017) (14)
- Data mining for longitudinal data under multicollinearity and time dependence using penalized generalized estimating equations (2012) (14)
- Cost-effectiveness of hepatitis A vaccination for adults in Belgium. (2012) (14)
- Optimizing agent-based transmission models for infectious diseases (2015) (14)
- Belgian population norms for the EQ-5D-5L, 2018 (2021) (14)
- Economic Aspects of Pneumococcal Pneumonia (2012) (13)
- Can COVID-19 symptoms as reported in a large-scale online survey be used to optimise spatial predictions of COVID-19 incidence risk in Belgium? (2020) (13)
- Infectious diseases epidemiology, quantitative methodology, and clinical research in the midst of the COVID-19 pandemic: Perspective from a European country (2020) (13)
- Universal hepatitis B vaccination in Belgium: impact on serological markers 3 and 7 years after implementation (2013) (13)
- Varicella-zoster virus vaccination under the exogenous boosting hypothesis: two ethical perspectives. (2014) (13)
- A trial like ALIC4E: why design a platform, response-adaptive, open, randomised controlled trial of antivirals for influenza-like illness? (2018) (13)
- Seasonal influenza vaccination: prioritizing children or other target groups? Part 2 : cost-effectiveness analysis (2013) (13)
- Common attitudes about concomitant vaccine injections for infants and adolescents in Flanders, Belgium. (2009) (13)
- The impact of non-financial and financial encouragements on participation in non school-based human papillomavirus vaccination: a retrospective cohort study (2016) (12)
- Time trends in social contacts before and during the COVID-19 pandemic: the CONNECT study (2021) (12)
- Cost–effectiveness of screening for active cases of tuberculosis in Flanders, Belgium (2016) (12)
- In-depth analysis of pneumococcal serotypes in Belgian children (2015-2018): Diversity, invasive disease potential, and antimicrobial susceptibility in carriage and disease. (2020) (12)
- Taking a COVID-19 Vaccine or Not? Do Trust in Government and Trust in Experts Help Us to Understand Vaccination Intention? (2022) (12)
- Economic Evaluation of Vaccines: Belgian Reflections on the Need for a Broader Perspective. (2020) (12)
- Herpes zoster is associated with herpes simplex and other infections in under 60 year-olds. (2015) (12)
- Cytomegalovirus seropositivity is associated with herpes zoster (2015) (12)
- Cost-effectiveness analysis of rotavirus vaccination of Belgian infants (2007) (12)
- Animal Ownership and Touching Enrich the Context of Social Contacts Relevant to the Spread of Human Infectious Diseases (2015) (12)
- Economic Evaluation of Vaccination Programmes in Older Adults and the Elderly: Important Issues and Challenges (2016) (11)
- Clustering of susceptible individuals within households can drive measles outbreaks: an individual-based model exploration (2019) (11)
- Respiratory syncytial virus and influenza virus infection in adult primary care patients: Association of age with prevalence, diagnostic features and illness course (2020) (11)
- The burden of respiratory syncytial virus in healthy term-born infants in Europe: a prospective birth cohort study (2022) (11)
- Valuing prevention through economic evaluation (2012) (11)
- Pharmacoeconomics of elderly vaccination against invasive pneumococcal infections: costeffectiveness analyses and implications for The Netherlands (2003) (11)
- The effect of apoptotic cells on virus-specific immune responses detected using IFN-gamma ELISPOT. (2010) (11)
- The disease burden of hepatitis B in Uzbekistan. (2000) (11)
- Cost-effectiveness of 10- and 13-valent pneumococcal conjugate vaccines in childhood (2011) (11)
- Cost-effectiveness analysis in melanoma detection: A transition model applied to dermoscopy. (2016) (10)
- Estimating Transmission Parameters for Respiratory Syncytial Virus and Predicting the Impact of Maternal and Pediatric Vaccination. (2020) (10)
- Estimation of the Force of Infection from Current Status Data Using Generalized Linear Mixed Models (2007) (10)
- Cost analysis in favor of a combined approach for cytomegalovirus after kidney transplantation: a single‐center experience (2013) (10)
- Retrospective cost-effectiveness of the 23-valent pneumococcal polysaccharide vaccination program in Australia. (2018) (10)
- Economic Evaluation of Vaccination (2012) (10)
- Structural differences in mixing behavior informing the role of asymptomatic infection and testing symptom heritability. (2017) (9)
- Medical costs of treatment and survival of patients with acute myeloid leukemia in Belgium. (2016) (9)
- Inferring rubella outbreak risk from seroprevalence data in Belgium. (2016) (9)
- Quality-of-life: a many-splendored thing? Belgian population norms and 34 potential determinants explored by beta regression (2017) (9)
- Cost-utility of vaccination against chickenpox in children and against herpes zoster in elderly in Belgium (2010) (9)
- Economic costs analysis of uncomplicated malaria case management in the Peruvian Amazon (2020) (9)
- Effects and costs of universal infant pneumococcal conjugate vaccination in Belgium (2006) (9)
- Distinct patterns of within-host virus populations between two subgroups of human respiratory syncytial virus (2021) (8)
- Simultaneous Viral Whole-Genome Sequencing and Differential Expression Profiling in Respiratory Syncytial Virus Infection of Infants. (2020) (8)
- Impact of long-COVID on health-related quality of life in Japanese COVID-19 patients (2021) (8)
- Estimating vaccination coverage for the trivalent measles–mumps–rubella vaccine from trivariate serological data (2012) (8)
- The HUMTICK study: protocol for a prospective cohort study on post-treatment Lyme disease syndrome and the disease and cost burden of Lyme borreliosis in Belgium (2017) (8)
- Environmental triggers of acute myocardial infarction: results of a nationwide multiple-factorial population study (2015) (8)
- Hospital Admission Trends for Bronchiolitis in Scotland, 2001-2016: A National Retrospective Observational Study. (2020) (8)
- The influence of risk perceptions on close contact frequency during the SARS-CoV-2 pandemic (2021) (8)
- Sponsorship Bias in Base-Case Values and Uncertainty Bounds of Health Economic Evaluations? A Systematic Review of Herpes Zoster Vaccination (2018) (8)
- The role of timeliness in the cost-effectiveness of older adult vaccination: A case study of pneumococcal conjugate vaccine in Australia. (2018) (8)
- Comments on the Prosser et al Approach to Value Disease Reduction in Children (2004) (8)
- Effectiveness of a Malaria Surveillance Strategy Based on Active Case Detection during High Transmission Season in the Peruvian Amazon (2018) (8)
- Hepatitis B in St Petersburg, Russia (1994–1999): incidence, prevalence and force of infection (2003) (8)
- Workplace influenza vaccination to reduce employee absenteeism: An economic analysis from the employers' perspective. (2021) (8)
- Effectiveness of seven-valent pneumococcal conjugate vaccine (2007) (7)
- Increased herpes zoster risk associated with poor HLA-A immediate early 62 protein (IE62) affinity (2018) (7)
- Indications for healthcare surge capacity in European countries facing an exponential increase in COVID19 cases (2020) (7)
- Recent quantitative research on determinants of health in high income countries: A scoping review (2020) (7)
- Modelling distortions in seroprevalence data using change-point fractional polynomials (2010) (7)
- The impact of maternal RSV vaccine to protect infants in Gavi-supported countries: Estimates from two models (2020) (7)
- Adaptive change-point mixed models applied to data on outpatient tetracycline use in Europe (2013) (6)
- Inferring age-specific differences in susceptibility to and infectiousness upon SARS-CoV-2 infection based on Belgian social contact data (2021) (6)
- No Such Thing as a Free-Rider? Understanding Drivers of Childhood and Adult Vaccination through a Multicountry Discrete Choice Experiment (2021) (6)
- Seroprevalence of IgG antibodies against SARS-CoV-2 – a serial prospective cross-sectional nationwide study of residual samples, Belgium, March to October 2020 (2022) (5)
- Presumed Risk Factors and Biomarkers for Severe Respiratory Syncytial Virus Disease and Related Sequelae: Protocol for an Observational Multicenter, Case-Control Study From the Respiratory Syncytial Virus Consortium in Europe (RESCEU). (2020) (5)
- CAREGIVERS’ WILLINGNESS TO PAY TO REDUCE THE NUMBER OF VACCINE INJECTIONS IN INFANTS (2009) (5)
- Cost-Effectiveness of Socioeconomic Support as Part of HIV Care for the Poor in an Urban Community-Based Antiretroviral Program in Uganda (2014) (5)
- [Opinions and attitudes of Flemish pharmacists and general practitioners towards INN prescribing. A survery in Antwerp and East Flanders]. (2013) (5)
- Do costs of varicella justify routine infant vaccination? (2004) (5)
- COVID-19 Vaccine Prioritisation in Japan and South Korea (2021) (4)
- [Pharmaco-economic aspects of vaccination against invasive pneumococcal infections in persons over 65 years of age; review of the literature on cost effectiveness analysis]. (2002) (4)
- Zoster in monasteries: some clarification needed. (2012) (4)
- [Varicella-zoster virus seroprevalence in nursery and day-care workers in Lyon (France)]. (2005) (4)
- A trial like ALIC 4 E: why design a platform, response-adaptive, open, randomised controlled trial of antivirals for influenza-like illness? (2018) (4)
- Supplementary material from "Behavioural change models for infectious disease transmission: a systematic review (2010–2015)" (2016) (4)
- The health and economic impact of acute gastroenteritis in Belgium, 2010–2014 (2019) (4)
- A spatial model to optimise predictions of COVID-19 incidence risk in Belgium using symptoms as reported in a large-scale online survey (2020) (4)
- Program evaluation of universal varicella vaccination in Belgium: preliminary results (2000) (4)
- Correction: Animal Ownership and Touching Enrich the Context of Social Contacts Relevant to the Spread of Human Infectious Diseases (2016) (4)
- Direct and Indirect Costs of Influenza-Like Illness Treated with and Without Oseltamivir in 15 European Countries: A Descriptive Analysis Alongside the Randomised Controlled ALIC4E Trial (2021) (4)
- Preexisting memory CD4 T cells in naïve individuals confer robust immunity upon vaccination (2020) (4)
- An ODE-based mixed modelling approach for B- and T-cell dynamics induced by Varicella-Zoster Virus vaccines in adults shows higher T-cell proliferation with Shingrix than with Varilrix. (2019) (4)
- Unveiling the Risk Period for Death After Respiratory Syncytial Virus Illness in Young Children Using a Self-Controlled Case Series Design. (2020) (4)
- Streptococcus pneumoniae Serotypes Carried by Young Children and Their Association With Acute Otitis Media During the Period 2016–2019 (2021) (3)
- Séroprévalence de l'immunité au virus de la varicelle et du zona chez le personnel de crèche et de halte-garderie à Lyon (France) (2005) (3)
- Serotype 19A and 6C Account for One-Third of Pneumococcal Carriage Among Belgian Day-Care Children Four Years After a Shift to a Lower-Valent PCV (2022) (3)
- Cost-Effectiveness Analysis of Herpes Zoster Vaccination in 50- to 85-Year-Old Immunocompetent Belgian Cohorts: A Comparison between No Vaccination, the Adjuvanted Subunit Vaccine, and Live-Attenuated Vaccine (2022) (3)
- Cost Analysis of Immunotherapy Using Dendritic Cells for Acute Myeloid Leukemia Patients (2014) (3)
- Economic Evaluation of Varicella Vaccination Programmes: A Review of the Literature. The Authors’ Reply (2004) (3)
- Response to comment on article by Jit et al. The cost effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe (2011) (3)
- Evolution over time in the cost-effectiveness of pneumococcal conjugate vaccine (PCV13) in older Australians due to herd protection from infant vaccination. (2018) (3)
- Quantitative research on health determinants in high-income countries: Systematic literature review (2019) (3)
- A Computationally Efficient Method for Probabilistic Parameter Threshold Analysis for Health Economic Evaluations (2020) (3)
- Medicine price awareness in chronic patients in Belgium. (2015) (3)
- Exploratory Analysis of the Economically Justifiable Price of a Hypothetical RSV Vaccine for Older Adults in the Netherlands and the United Kingdom (2021) (3)
- ECONOMIC EVALUATIONS OF PNEUMOCOCCAL VACCINATION STRATEGIES IN ADULTS. A SUMMARY OF THE RESULTS. (2005) (3)
- Value Frameworks for Vaccines: Which Dimensions Are Most Relevant? (2020) (3)
- Evolutions in Both Co-Payment and Generic Market Share for Common Medication in the Belgian Reference Pricing System (2013) (3)
- Altered CD4+ T cell immunity in nurses occupationally exposed to viral pathogens (2018) (3)
- Exploratory Analysis of the Economically Justifiable Price of a Hypothetical RSV Vaccine for Older Adults in the Netherlands and the United Kingdom (2021) (3)
- Impact of Adding Oseltamivir to Usual Care on Quality-Adjusted Life-Years During Influenza-Like Illness. (2021) (2)
- Cost-Effectiveness of Hepatitis a Vaccination in Indonesia. (2014) (2)
- An ODE-based mixed modelling approach for B- and T-cell dynamics induced by Varicella-Zoster Virus vaccines in adults shows higher T-cell proliferation with Shingrix compared to Varilrix (2018) (2)
- Social Contact Rates (SOCRATES) Data Tool (2020) (2)
- Multi-Country Model Application for RSV Cost-Effectiveness Policy (McMarcel) (2020) (2)
- Aggregate Wellbeing as Foundation to Discourage Childhood Chickenpox Vaccination (2020) (2)
- Cost Effectiveness of Alternative Hepatitis A Immunisation Strategies (1995) (2)
- What counts in cytometric analysis to document vaccine immunogenicity? (2012) (2)
- No such thing as a free-rider? Understanding multicountry drivers of childhood and adult vaccination (2020) (2)
- Care-seeking behaviour and socio-economic burden associated with uncomplicated malaria in the Democratic Republic of Congo (2021) (2)
- Estimating the Force of Infection from Incidence and Prevalence (2012) (2)
- Evaluations économiques de la vaccination pneumococcique : Analyse critique (1998) (2)
- Social preferences for adopting new vaccines in the national immunization program: A discrete choice experiment. (2022) (2)
- Pregnancy during COVID-19: social contact patterns and vaccine coverage of pregnant women from CoMix in 19 European countries (2022) (2)
- UK experience of herpes zoster vaccination can inform varicella zoster virus policies. (2017) (2)
- Economic evaluation of childhood vaccines (2009) (2)
- Methods for Health Economic Evaluations of Vaccines - Results from an International Expert-Workshop. (2014) (2)
- Hepatitis A vaccine for secondary hepatitis A infection (1999) (2)
- Streptococcus pneumoniae serotypes carried by young children and their association with Acute Otitis Media during the period 2016 – 2019 (2020) (2)
- Sampling Site Matters When Counting Lymphocyte Subpopulations (2012) (2)
- Economic Burden and Health-Related Quality of Life of Respiratory Syncytial Virus and Influenza Infection in European Community-Dwelling Older Adults. (2022) (2)
- Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. (2011) (2)
- Preexisting memory CD4 T cells in naïve individuals confer robust immunity upon hepatitis B vaccination (2022) (2)
- Belgian population norms for the EQ-5D-5L, 2013 and 2018 (2020) (2)
- Social contact patterns during the COVID-19 pandemic in 21 European countries – evidence from a two-year study (2022) (2)
- Different forms of superspreading lead to different outcomes: Heterogeneity in infectiousness and contact behavior relevant for the case of SARS-CoV-2 (2022) (1)
- Cost-effectiveness of varicella and zoster vaccination in England&Wales: importance measures for correlated parameters (2010) (1)
- Cost-effectiveness of Respiratory Syncytial Virus Disease Prevention Strategies: Maternal Vaccine Versus Seasonal or Year-Round Monoclonal Antibody Program in Norwegian Children. (2022) (1)
- Nonparametric Approaches to Model the Prevalence and Force of Infection (2012) (1)
- Protecting European health care workers against hepatitis B: a preliminary economic evaluation (1995) (1)
- Transcriptomic profiling of different responder types in adults after a Priorix® vaccination. (2020) (1)
- PIN16 COMPARATIVE CRITICAL REVIEW OF COST-EFFECTIVENESS TOOLS OF PNEUMOCOCCAL CONJUGATE VACCINE (PCV) (2010) (1)
- Economic evaluation in travel medicine (1997) (1)
- Costs of management of acute respiratory infections in older adults: A systematic review and meta-analysis (2022) (1)
- Lyme borreliosis in Belgium: a cost-of-illness analysis (2022) (1)
- Cost-effectiveness of hepatitis B vaccination in low-endemic countries (1997) (1)
- Social contact data from CoMix survey (Belgium) (2020) (1)
- Links Between Herpes Zoster Incidence and Childhood Varicella Vaccination (2014) (1)
- Assumptions were confusing (1995) (1)
- The seroprevalence of cytomegalovirus infection in Belgium anno 2002 and 2006: a comparative analysis with hepatitis A virus seroprevalence (2019) (1)
- [Economic evaluations of pneumococcal vaccination. A critical analysis]. (1998) (1)
- Priority-Setting and Personality: Effects of Dispositional Optimism on Preferences for Allocating Healthcare Resources (2019) (1)
- Environmental triggers of acute myocardial infarction: does air pollution matter? (2013) (1)
- Generating, Presenting, and Interpreting Cost-Effectiveness Results in the Context of Uncertainty: A Tutorial for Deeper Knowledge and Better Practice (2021) (1)
- Social contact and mixing patterns relevant to the spread of infectious diseases: a multi-country population-based survey (2007) (1)
- Long-term persistence of anti-HAV antibodies: model-based calculations of long-term persistence of anti-HAV antibodies after vaccination (1997) (1)
- Cs SEASONAL INFLUENZA VACCINATION : PRIORITIZING CHILDREN OR OTHER TARGET GROUPS ? PART II : COST-EFFECTIVENESS ANALYSIS – SYNTHESIS (2013) (1)
- Physicians Poster SessionsPoster Session / Day 1 (2015) (1)
- Cost-effectiveness of respiratory syncytial virus preventive interventions in children: a model comparison study. (2022) (1)
- Author Correction: Multidisciplinary study of the secondary immune response in grandparents re-exposed to chickenpox (2018) (1)
- COL 2-03 - Le risque de résurgence de la rougeole, des oreillons et de la rubéole en France en 2016 (2016) (1)
- SOCRATES: an online tool leveraging a social contact data sharing initiative to assess mitigation strategies for COVID-19 (2020) (1)
- The influence of COVID-19 risk perception and vaccination status on the number of social contacts across Europe: insights from the CoMix study (2022) (1)
- Unintended consequences of co-payment regulations in Belgium: the case of atorvastatin (2015) (1)
- Economic aspects of vaccines and vaccination: a global perspective (2005) (1)
- The SIR Model (2012) (1)
- Unintended consequences of co-payment regulations in Belgium: the case of atorvastatin (2015) (1)
- The Constraint of Monotonicity (2012) (1)
- Evidence-based prevention of cannabis use in flanders is there a role for health economic evaluation? (2010) (1)
- 'Egocentric' Vaccination: The Authors Reply. (2016) (1)
- Using an adaptive trial design for an infectious disease in primacy care - challenges in the design and set-up stages (2015) (1)
- Modeling Multivariate Serological Data (2012) (0)
- Cost-effectiveness of monoclonal antibody and maternal immunization against respiratory syncytial virus (RSV) in infants: Evaluation for six European countries. (2023) (0)
- Correction (2014) (0)
- Universal chickenpox vaccination of infants may be cost-saving to society, but better studies are needed (2003) (0)
- PIN29 ECONOMIC EVALUATION OF MENINGOCOCCAL C VACCINATION PROGRAMMES AND ITS IMPACT ON DECISION MAKING (2004) (0)
- Characterization of the treatment trajectory and assessment of the disease weight during uncomplicated malaria in the Democratic Republic of Congo (2019) (0)
- Economic costs analysis of uncomplicated malaria case management in the Peruvian Amazon (2020) (0)
- Corrigendum to "Cost-effectiveness analysis in melanoma detection: A transition model applied to dermoscopy" [Eur J Cancer 67 (2016) 38-45]. (2017) (0)
- Cost-effectiveness of adding oseltamivir to primary care for influenza-like-illness: economic evaluation alongside the randomised controlled ALIC4E trial in 15 European countries. (2022) (0)
- S0950268821002569jra 1..7 (2022) (0)
- Exponential-family random graph models for within-household contact networks (2014) (0)
- Social contact patterns in Japan in the COVID-19 pandemic during and after the Tokyo Olympic Games (2022) (0)
- Optimizing agent-based transmission models for infectious diseases (2015) (0)
- PIN42 Methodological Decisions in Economic Evaluations of Childhood Influenza Vaccination: Findings from a Literature Review (2011) (0)
- Pharmacoeconomics 2004; 22 (18): 1171-1179 (2004) (0)
- Who Acquires Infection from Whom? The Traditional Approach (2012) (0)
- Prevention of hepatitis A: economic aspects (1995) (0)
- Integrating mathematical modeling, computational thinking and ICT applications (2008) (0)
- Authors’ Reply to Comment on “Cost-Effectiveness Analysis of Herpes Zoster Vaccination in 50- to 85-Year-Old Immunocompetent Belgian Cohorts: A Comparison Between No Vaccination, the Adjuvanted Subunit Vaccine, and Live-Attenuated Vaccine” (2022) (0)
- A spatial model to jointly analyze self‐reported survey data of COVID‐19 symptoms and official COVID‐19 incidence data (2022) (0)
- The Lancet Regional Health-Europe (2021) (0)
- Cost analysis of dendritic cell therapy for acute myeloid leukemia patients (2015) (0)
- Corrigendum to 'Individual decisions to vaccinate one's child or oneself: A discrete choice experiment rejecting free-riding motives' Soc. Sci. Med. 207 (2018) 106-116. (2018) (0)
- [Splenectomy and pneumococcal vaccination]. (2003) (0)
- Data Sources for Modeling Infectious Diseases (2012) (0)
- Investigating confounding in network‐based test‐negative design influenza vaccine effectiveness studies—Experience from the DRIVE project (2022) (0)
- Do contacts over distance follow a power-law distribution? Estimation of the social contact distance kernel (2015) (0)
- Histogram of the estimated extra costs of sequential digital dermoscopy imaging versus optical dermoscopy. (2014) (0)
- Epidémie d'Ebola: une réponse internationale qui bafouille (2014) (0)
- COL 09-01 - Facteurs socio-démographiques influant la propagation d’une épidémie : utilisation des données de contact (2013) (0)
- Community Acquired Pneumonia (CAP) hospitalisations and deaths: is there a quality improvement role for inter-hospital comparisons? (2015) (0)
- Ceci n'est pas un lit. Base capacity healthcare matters in a pandemic (2021) (0)
- Modeling the Prevalence and the Force of Infection Directly from Antibody Levels (2012) (0)
- [Not Available]. (2016) (0)
- Évaluations économiques des vaccins pédiatriques (2000) (0)
- Avis et attitudes des pharmaciens et des médecins généralistes vis-à -vis de la prescription en DCI : enquête réalisée à Anvers et en Flandre Orientale (2013) (0)
- Epidémie d'Ebola : une réponse internationale qui bafouille (2014) (0)
- Catching the risk of measles outbreaks in a clustered society (2017) (0)
- EE622 Cost-Effectiveness of Respiratory Syncytial Virus (RSV) Prevention Interventions in Children: A Model Comparison Study (2022) (0)
- Informing WAIFW with Data on Social Contacts (2012) (0)
- Author Correction: Multidisciplinary study of the secondary immune response in grandparents re-exposed to chickenpox (2018) (0)
- Computational Statistics and Data Analysis Data mining for longitudinal data under multicollinearity and time dependence using penalized generalized estimating equations ✩ (2015) (0)
- Detection of SARS-CoV-2 in young children attending day-care centres in Belgium, May 2020 to February 2022 (2022) (0)
- INDIVIDUAL-BASED MODELS: POWERFUL OR POWER STRUGGLE? (2015) (0)
- Economic Evaluation of Vaccination ProgrammesStatement Focusing on Viral Hepatitis (2002) (0)
- Author response: Integrating between-host transmission and within-host immunity to analyze the impact of varicella vaccination on zoster (2015) (0)
- Priority-Setting and Personality: Effects of Dispositional Optimism on Preferences for Allocating Healthcare Resources (2019) (0)
- Care-seeking behaviour and socio-economic burden associated with uncomplicated malaria in the Democratic Republic of Congo (2021) (0)
- Memory CD4+ T cell receptor repertoire data mining as a tool for identifying cytomegalovirus serostatus (2018) (0)
- What hinders general practitioners to prescribe cheaper? The use of International Non-proprietary Name (INN) in Belgium (2014) (0)
- The future’s so bright, I gotta wear sunscreen: Dispositional optimism and preferences for prioritizing health care (2015) (0)
- Not as easy as it sounds: Challenges in assessing the value for money of implemented vaccination programs (2014) (0)
- The burden of isolation to the individual: a comparison between isolation for COVID-19 and for other influenza-like illnesses in Japan (2021) (0)
- Revealing age-specific past and future unrelated costs of pneumococcal infections by flexible generalized estimating equations (2011) (0)
- Determinants of basic childhood vaccination coverage in European and OECD countries (2022) (0)
- Acknowledgement to Referees (2017) (0)
- The disability adjusted life years (DALYs) and economic burden due to haemophilia in Belgium (2014) (0)
- Economic Impact of Influenza: The Macro Perspective (2007) (0)
- Hierarchical Nonparametric Bayesian Models for the Force of Infection for Mumps and Rubella (0)
- Factors driving choices between types and brands of influenza vaccines in general practice in Austria, Italy, Spain and the UK (2021) (0)
- How can early stage economic evaluation help guide research for future vaccines? (2021) (0)
- Multi-view learning to unravel the different levels underlying hepatitis B vaccine response (2023) (0)
- Partially Wrong? Partial Equilibrium and the Economic Analysis of Infectious Disease Interventions (2007) (0)
- Why This Book? An Introduction (2012) (0)
- The influence of risk perceptions on close contact frequency during the SARS-CoV-2 pandemic (2022) (0)
- The estimated disease burden of COVID-19 in Japan from 2020 to 2021 (2022) (0)
- The Sexual Ethics of HPV Vaccination for Boys (2013) (0)
- Placing a value on increased flexible vaccine manufacturing capacity for future pandemics (2023) (0)
- Modeling antibody dynamics following herpes zoster indicates that higher varicella-zoster virus viremia generates more VZV-specific antibodies (2023) (0)
- Safe water or hepatitis B vaccination in India: general comments (1999) (0)
- A Priori and A Posteriori Models for Infectious Diseases (2012) (0)
- Cervical cancer screening based on urine self-sampling to reach un(der)-screened women: study protocol of the ScreenUrSelf trial (2023) (0)
- PIN25 EXPLORATORY ANALYSIS OF THE ECONOMICALLY JUSTIFIABLE PRICE OF AN RSV VACCINE FOR THE ELDERLY IN THE NETHERLANDS AND THE UNITED KINGDOM (2019) (0)
- Increased herpes zoster risk associated with poor HLA-A immediate early 62 protein (IE62) affinity (2017) (0)
- Opinions and attitudes of pharmacists and general physicians towards INN presscribing in Flanders (2013) (0)
- Estimating transmission parameters using social contact data and serological data. (2008) (0)
- Exploring human mixing patterns based on time use and social contact data and their implications for infectious disease transmission models (2022) (0)
- Universele hepatitis B-vaccinatie in Vlaanderen (2000) (0)
- Estimating the cost-effectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South Africa (2022) (0)
- Estimating Age-Time Dependent Prevalence and Force of Infection from Serial Prevalence Data (2012) (0)
- Economic burden and health-related quality-of-life among infants with respiratory syncytial virus infection: A multi-country prospective cohort study in Europe. (2023) (0)
- Reply to letter: Retrospective cost-effectiveness of the 23-valent pneumococcal polysaccharide vaccination program in Australia. (2019) (0)
- Haemophilus influenzae carriage and antibiotic resistance profile in Belgian infants over a three-year period (2016–2018) (2023) (0)
- Cannabispreventie te soft voor harde waarheid (2006) (0)
- The in uence of risk perceptions on close contact frequency during the SARS-CoV-2 pandemic (2021) (0)
- Hierarchical Bayesian Models for the Force of Infection (2012) (0)
- Dynamics of non-household contacts during the COVID-19 pandemic in 2020 and 2021 in the Netherlands (2022) (0)
- Preexisting memory CD 4 T cells in naïve individuals confer robust 1 immunity upon hepatitis B vaccination 2 Running title : Preexisting memory T cells confer immunity to vaccination 3 (2021) (0)
- Integrating Estimated Parameters in a Basic SIR Model (2012) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Philippe Beutels?
Philippe Beutels is affiliated with the following schools: